Your browser doesn't support javascript.
loading
Autosomal dominant mitochondrial membrane protein-associated neurodegeneration (MPAN).
Gregory, Allison; Lotia, Mitesh; Jeong, Suh Young; Fox, Rachel; Zhen, Dolly; Sanford, Lynn; Hamada, Jeff; Jahic, Amir; Beetz, Christian; Freed, Alison; Kurian, Manju A; Cullup, Thomas; van der Weijden, Marlous C M; Nguyen, Vy; Setthavongsack, Naly; Garcia, Daphne; Krajbich, Victoria; Pham, Thao; Woltjer, Randy; George, Benjamin P; Minks, Kelly Q; Paciorkowski, Alexander R; Hogarth, Penelope; Jankovic, Joseph; Hayflick, Susan J.
Afiliación
  • Gregory A; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Lotia M; Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas.
  • Jeong SY; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Fox R; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Zhen D; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Sanford L; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Hamada J; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Jahic A; Department of Clinical Chemistry, Jena University Hospital, Jena, Germany.
  • Beetz C; Department of Clinical Chemistry, Jena University Hospital, Jena, Germany.
  • Freed A; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Kurian MA; Developmental Neurosciences, GOSH-Institute of Child Health, UCL & Department of Neurology, Great Ormond Street Hospital, London, UK.
  • Cullup T; North East Thames Regional Genetics Laboratory, London, UK.
  • van der Weijden MCM; Department of Neurology, University Medical Center Groningen, Groningen, The Netherlands.
  • Nguyen V; Pathology, Oregon Health & Science University, Portland, Oregon.
  • Setthavongsack N; Pathology, Oregon Health & Science University, Portland, Oregon.
  • Garcia D; Pathology, Oregon Health & Science University, Portland, Oregon.
  • Krajbich V; Pathology, Oregon Health & Science University, Portland, Oregon.
  • Pham T; Pathology, Oregon Health & Science University, Portland, Oregon.
  • Woltjer R; Pathology, Oregon Health & Science University, Portland, Oregon.
  • George BP; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Minks KQ; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Paciorkowski AR; Department of Neurology, University of Rochester Medical Center, Rochester, New York.
  • Hogarth P; Departments of Pediatrics, Biomedical Genetics, and Neuroscience, University of Rochester Medical Center, Rochester, New York.
  • Jankovic J; Molecular & Medical Genetics, Pediatrics and Neurology, Oregon Health & Science University, Portland, Oregon.
  • Hayflick SJ; Parkinson's Disease Center and Movement Disorder Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas.
Mol Genet Genomic Med ; 7(7): e00736, 2019 07.
Article en En | MEDLINE | ID: mdl-31087512
ABSTRACT

BACKGROUND:

Mitochondrial membrane protein-associated neurodegeneration (MPAN) is caused by pathogenic sequence variants in C19orf12. Autosomal recessive inheritance has been demonstrated. We present evidence of autosomal dominant MPAN and propose a mechanism to explain these cases.

METHODS:

Two large families with apparently dominant MPAN were investigated; additional singleton cases of MPAN were identified. Gene sequencing and multiplex ligation-dependent probe amplification were used to characterize the causative sequence variants in C19orf12. Post-mortem brain from affected subjects was examined.

RESULTS:

In two multi-generation non-consanguineous families, we identified different nonsense sequence variations in C19orf12 that segregate with the MPAN phenotype. Brain pathology was similar to that of autosomal recessive MPAN. We additionally identified a preponderance of cases with single heterozygous pathogenic sequence variants, including two with de novo changes.

CONCLUSIONS:

We present three lines of clinical evidence to demonstrate that MPAN can manifest as a result of only one pathogenic C19orf12 sequence variant. We propose that truncated C19orf12 proteins, resulting from nonsense variants in the final exon in our autosomal dominant cohort, impair function of the normal protein produced from the non-mutated allele via a dominant negative mechanism and cause loss of function. These findings impact the clinical diagnostic evaluation and counseling.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Distrofias Neuroaxonales / Trastornos del Metabolismo del Hierro / Proteínas Mitocondriales / Proteínas de la Membrana Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mol Genet Genomic Med Año: 2019 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Distrofias Neuroaxonales / Trastornos del Metabolismo del Hierro / Proteínas Mitocondriales / Proteínas de la Membrana Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mol Genet Genomic Med Año: 2019 Tipo del documento: Article